These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 29945210)
1. SC1 inhibits the differentiation of F9 embryonic carcinoma cells induced by retinoic acid. Liu Y; Ren X; Ke J; Zhang Y; Wei Q; Shi Z; Ai Z; Guo Z Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):793-799. PubMed ID: 29945210 [TBL] [Abstract][Full Text] [Related]
2. Oct4 and the small molecule inhibitor, SC1, regulates Tet2 expression in mouse embryonic stem cells. Wu Y; Guo Z; Liu Y; Tang B; Wang Y; Yang L; Du J; Zhang Y Mol Biol Rep; 2013 Apr; 40(4):2897-906. PubMed ID: 23254757 [TBL] [Abstract][Full Text] [Related]
3. SC1 Promotes MiR124-3p Expression to Maintain the Self-Renewal of Mouse Embryonic Stem Cells by Inhibiting the MEK/ERK Pathway. Wei Q; Liu H; Ai Z; Wu Y; Liu Y; Shi Z; Ren X; Guo Z Cell Physiol Biochem; 2017; 44(5):2057-2072. PubMed ID: 29241165 [TBL] [Abstract][Full Text] [Related]
4. E-cadherin is critical for SC1-induced colony growth of F9 embryonic carcinoma cells. Du J; Wu Y; Liu Y; Ai Z; Wu H; Shi X; Guo Z; Zhang Y Cell Physiol Biochem; 2014; 33(2):501-12. PubMed ID: 24556957 [TBL] [Abstract][Full Text] [Related]
5. Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. Li JY; Pu MT; Hirasawa R; Li BZ; Huang YN; Zeng R; Jing NH; Chen T; Li E; Sasaki H; Xu GL Mol Cell Biol; 2007 Dec; 27(24):8748-59. PubMed ID: 17938196 [TBL] [Abstract][Full Text] [Related]
6. Nanog, Oct4 and Tet1 interplay in establishing pluripotency. Olariu V; Lövkvist C; Sneppen K Sci Rep; 2016 May; 6():25438. PubMed ID: 27146218 [TBL] [Abstract][Full Text] [Related]
7. Disassociation of MAPK activation and c-Fos expression in F9 embryonic carcinoma cells following retinoic acid-induced endoderm differentiation. Smith ER; Smedberg JL; Rula ME; Hamilton TC; Xu XX J Biol Chem; 2001 Aug; 276(34):32094-100. PubMed ID: 11402055 [TBL] [Abstract][Full Text] [Related]
8. Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells. Soprano DR; Teets BW; Soprano KJ Vitam Horm; 2007; 75():69-95. PubMed ID: 17368312 [TBL] [Abstract][Full Text] [Related]
9. SC1 sustains the self-renewal capacity and pluripotency of chicken blastodermal cells by inhibiting the phosphorylation of ERK1 and promoting the phosphorylation of Akt. Li R; Tang X; Xu S; Chen Q; Chen B; Liu S; Li B; Li W; Yao Y; Wu W; Liu H Reprod Domest Anim; 2018 Oct; 53(5):1052-1059. PubMed ID: 30028046 [TBL] [Abstract][Full Text] [Related]
10. The phosphoinositide-3-kinase/Akt pathway mediates the transient increase in Nanog expression during differentiation of F9 cells. Kim JS; Kim BS; Kim J; Park CS; Chung IY Arch Pharm Res; 2010 Jul; 33(7):1117-25. PubMed ID: 20661723 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Freberg CT; Dahl JA; Timoskainen S; Collas P Mol Biol Cell; 2007 May; 18(5):1543-53. PubMed ID: 17314394 [TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of the Wilms tumor suppressor gene WT1 in F9 embryonal carcinoma cells induces apoptotic cell death in response to retinoic acid. Kudoh T; Ishidate T; Nakamura T; Toyoshima K; Akiyama T Oncogene; 1996 Oct; 13(7):1431-9. PubMed ID: 8875981 [TBL] [Abstract][Full Text] [Related]
13. Characterization of genes which exhibit reduced expression during the retinoic acid-induced differentiation of F9 teratocarcinoma cells: involvement of cyclin D3 in RA-mediated growth arrest. Faria TN; LaRosa GJ; Wilen E; Liao J; Gudas LJ Mol Cell Endocrinol; 1998 Aug; 143(1-2):155-66. PubMed ID: 9806360 [TBL] [Abstract][Full Text] [Related]
14. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells]. Chuĭkin IA; Lianguzova MS; Pospelov VA Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838 [TBL] [Abstract][Full Text] [Related]
15. Roles of the Nanog protein in murine F9 embryonal carcinoma cells and their endoderm-differentiated counterparts. Chen Y; Du Z; Yao Z Cell Res; 2006 Jul; 16(7):641-50. PubMed ID: 16773043 [TBL] [Abstract][Full Text] [Related]
16. Histone Modifications on the Promoters of Human OCT4 and NANOG Genes at the Onset of Neural Differentiation of NT2/D1 Cells. Topalovic V; Schwirtlich M; Stevanovic M; Mojsin M Biochemistry (Mosc); 2017 Jun; 82(6):715-722. PubMed ID: 28601081 [TBL] [Abstract][Full Text] [Related]
17. Comparative epigenetic analysis of Oct4 regulatory region in RA-induced differentiated NT2 cells under adherent and non-adherent culture conditions. Favaedi R; Shahhoseini M; Akhoond MR Mol Cell Biochem; 2012 Apr; 363(1-2):129-34. PubMed ID: 22160855 [TBL] [Abstract][Full Text] [Related]
18. The vimentin promoter as a tool to analyze the early events of retinoic acid-induced differentiation of cultured embryonal carcinoma cells. Benazzouz A; Duprey P Differentiation; 1999 Nov; 65(3):171-80. PubMed ID: 10631814 [TBL] [Abstract][Full Text] [Related]
19. RG108 increases NANOG and OCT4 in bone marrow-derived mesenchymal cells through global changes in DNA modifications and epigenetic activation. Assis RIF; Wiench M; Silvério KG; da Silva RA; Feltran GDS; Sallum EA; Casati MZ; Nociti FH; Andia DC PLoS One; 2018; 13(12):e0207873. PubMed ID: 30507955 [TBL] [Abstract][Full Text] [Related]
20. FOXC1 Downregulates Nanog Expression by Recruiting HDAC2 to Its Promoter in F9 Cells Treated by Retinoic Acid. Xue H; Liu F; Ai Z; Ke J; Yu M; Chen B; Guo Z Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]